Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 4, 2009, Pages 272-275

  Merçon, Monica ^a   Tuboi, Suely H ^a   Batista, Sônia Maria ^a   Telles, Sandra Regina Barros ^a   Grangeiro, José Roberto ^a   Zajdenverg, Roberto ^a   Do Lago, Regina Ferrox ^a   Barroso, Paulo Feijó ^a   Melo, Maria De Fátima ^a   Schechter, Mauro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

HIV; HIV prevention; STARHS, HIV seroconversion, VCT; Steady partner

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BRAZIL; COUNSELING; CROSS-SECTIONAL STUDY; EPIDEMIC; FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY;

ADULT; ALGORITHMS; BRAZIL; CHRONIC DISEASE; COUNSELING; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 77949780391     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000400006     Document Type: Article

References (12)

1. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Jama 1998;280(1):42-8.
2. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18(4):295-307.
3. CDC. BED-CEIA Incidence and Adjustment Formula. Available at www.cdc.gov/nchstp/od/GAP/docs/surveillance/BED- CEIA%20Incidence%20and%20Adjustment%20Formula.pdf 2006.
4. Schechter M, do Lago RF, de Melo MF, et al. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projeto Praco Onze Study Group. J Acquir Immune Defic Syndr 2000;24(2): 175-7.
5. Barroso PF, Harrison LH, de Fatima Melo M, et al. Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: an update. J Acquir Immune Defic Syndr 2004;36(3):880-1.
6. Alves K, Shafer KP, Caseiro M, et al. Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999. J Acquir Immune Defic Syndr 2003;32(5):551-9.
7. Schwarcz S, Weinstock H, Louie B, et al. Characteristics of persons with recently acquired HIV infection: application of the serologic testing algorithm for recent HIV seroconversion in 10 US cities. J Acquir Immune Defic Syndr 2007;44(1):112-5.
8. Nash D, Bennani Y, Ramaswamy C, Torian L. Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassy, New York City, 2001. J Acquir Immune Defic Syndr 2005;39(1):102-11.
9. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. Aids 2007;21(4):403-8.
10. Morgado MG, Guimaraes ML, Gripp CB, et al. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(5):488-94.
11. Bello G, Eyer-Silva WA, Couto-Fernandez JC, et al. Demographic history of HIV-1 subtypes B and F in Brazil. Infect Genet Evol 2007;7(2):263-70.
12. Barroso PF, de Souza MB, do Lago RF, et al. Barriers to Recruit Female Commercial Sex Workers for HIV Vaccine Trials: The Rio de Janeiro Experience. J Acquir Immune Defic Syndr 2009;50(1):116-117.